Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Insilico Medicine

AI drug discovery firm Insilico Medicine signs deal with Korea’s SK Biopharmaceuticals worth $2.5 billion

“We want to be the SpaceX of the pharmaceutical industry,” Alex Zhavoronkov, co-CEO of Insilico Medicine, tells Fortune.

Eli Lilly's $2.75 Billion AI Bet on Anti-Aging Drugs Signals a Major Shift in Pharmaceutical Priorities

Eli Lilly's $2.75 Billion AI Bet on Anti-Aging Drugs Signals a Major Shift in Pharmaceutical Priorities

Eli Lilly's $2.75B AI deal with Insilico Medicine targets age-related diseases. How AI is transforming longevity drug discovery and what it means for patients.

Eli Lilly Is Bringing AI-Developed Drugs to Market. Should You Buy LLY Stock to Profit?

Eli Lilly Is Bringing AI-Developed Drugs to Market. Should You Buy LLY Stock to Profit?

Eli Lilly has expanded its partnership with Insilico Medicine to bring AI developed medicine into global market.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Eli Lilly invests in AI-designed drugs in new deal with Insilico Medicine worth up to €2.39bn

Eli Lilly has partnered with AI biotech Insilico Medicine for exclusive global rights to develop and commercialise medicines designed entirely by artificial intelligence.

AI drug startup Insilico Medicine launches an AI ‘gym’ to help models like GPT and Qwen be good at science

With the “gym,” Insilico is now targeting other biotech and pharmaceutical companies, offering to train new AI models for them.

Is AI The Key To Beating Cancer? Why Pharma Stocks Are Soaring

Something big is happening in healthcare, as pharma stocks have recently rallied on breakthrough AI developments that could reshape the entire industry.

CEOs share how AI is shaking up the workforce—including an instance of 'robots outcompeting humans in real time'

Chinese startups can develop digital avatars almost as good as human streamers using just a few minutes of footage, noted McKinsey's Rodney Zimmel.

inkl

Read news from The Economist, FT, and more,
with one subscription

Aging is the inflation of life. An emerging crop of longevity biotech companies needs investment to beat it

Aging is the inflation of life. An emerging crop of longevity biotech companies needs investment to beat it

A new generation of longevity biotech companies with a more conservative approach than their predecessors has emerged—but investment remains constrained.

Only an AI breakthrough can help humans live longer, argues drug developer: 'We need a ChatGPT moment in longevity'

Only an AI breakthrough can help humans live longer, argues drug developer: 'We need a ChatGPT moment in longevity'

Insilico Medicine's founder warns behavioral modification through sleep, diet and exercise has exhausted its potential to extend the average lifespan.

5 astonishing uses of AI happening right now

5 astonishing uses of AI happening right now

From making medical discoveries to changing the way we play games, generative AI is recreating our world

1

People

Barbara Humpton

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

McKinsey Company

Insilico Medicine

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

389,904 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play